178 related articles for article (PubMed ID: 29039946)
1. Phenylpropenoids from Bupleurum fruticosum as Anti-Human Rhinovirus Species A Selective Capsid Binders.
Fois B; Bianco G; Sonar VP; Distinto S; Maccioni E; Meleddu R; Melis C; Marras L; Pompei R; Floris C; Caboni P; Cottiglia F
J Nat Prod; 2017 Oct; 80(10):2799-2806. PubMed ID: 29039946
[TBL] [Abstract][Full Text] [Related]
2. A novel benzonitrile analogue inhibits rhinovirus replication.
Lacroix C; Querol-Audí J; Roche M; Franco D; Froeyen M; Guerra P; Terme T; Vanelle P; Verdaguer N; Neyts J; Leyssen P
J Antimicrob Chemother; 2014 Oct; 69(10):2723-32. PubMed ID: 24948704
[TBL] [Abstract][Full Text] [Related]
3. A Novel Series of Highly Potent Small Molecule Inhibitors of Rhinovirus Replication.
Kim J; Jung YK; Kim C; Shin JS; Scheers E; Lee JY; Han SB; Lee CK; Neyts J; Ha JD; Jung YS
J Med Chem; 2017 Jul; 60(13):5472-5492. PubMed ID: 28581749
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and anti-rhinovirus activity of novel 3-[2-(pyridinyl)vinyl]substituted -2H-chromenes and -4H-chromen-4-ones.
Conti C; Proietti Monaco L; Desideri N
Bioorg Med Chem; 2014 Feb; 22(3):1201-7. PubMed ID: 24360829
[TBL] [Abstract][Full Text] [Related]
5. Structure-Based Drug Design of Potent Pyrazole Derivatives against Rhinovirus Replication.
Da Costa L; Scheers E; Coluccia A; Casulli A; Roche M; Di Giorgio C; Neyts J; Terme T; Cirilli R; La Regina G; Silvestri R; Mirabelli C; Vanelle P
J Med Chem; 2018 Sep; 61(18):8402-8416. PubMed ID: 30153009
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and activity of piperazine-containing antirhinoviral agents and crystal structure of SDZ 880-061 bound to human rhinovirus 14.
Oren DA; Zhang A; Nesvadba H; Rosenwirth B; Arnold E
J Mol Biol; 1996 May; 259(1):120-34. PubMed ID: 8648640
[TBL] [Abstract][Full Text] [Related]
7. VP1 sequencing of all human rhinovirus serotypes: insights into genus phylogeny and susceptibility to antiviral capsid-binding compounds.
Ledford RM; Patel NR; Demenczuk TM; Watanyar A; Herbertz T; Collett MS; Pevear DC
J Virol; 2004 Apr; 78(7):3663-74. PubMed ID: 15016887
[TBL] [Abstract][Full Text] [Related]
8. New class of early-stage enterovirus inhibitors with a novel mechanism of action.
Ma Y; Abdelnabi R; Delang L; Froeyen M; Luyten W; Neyts J; Mirabelli C
Antiviral Res; 2017 Nov; 147():67-74. PubMed ID: 28993161
[TBL] [Abstract][Full Text] [Related]
9. 3-Phenylalkyl-2H-chromenes and -chromans as novel rhinovirus infection inhibitors.
Conti C; Proietti Monaco L; Desideri N
Bioorg Med Chem; 2017 Apr; 25(7):2074-2083. PubMed ID: 28242170
[TBL] [Abstract][Full Text] [Related]
10. Selective human enterovirus and rhinovirus inhibitors: An overview of capsid-binding and protease-inhibiting molecules.
Shih SR; Chen SJ; Hakimelahi GH; Liu HJ; Tseng CT; Shia KS
Med Res Rev; 2004 Jul; 24(4):449-74. PubMed ID: 15170592
[TBL] [Abstract][Full Text] [Related]
11. New 4H-chromen-4-one and 2H-chromene derivatives as anti-picornavirus capsid-binders.
Conti C; Desideri N
Bioorg Med Chem; 2010 Sep; 18(17):6480-8. PubMed ID: 20673722
[TBL] [Abstract][Full Text] [Related]
12. Cryo-EM structure of pleconaril-resistant rhinovirus-B5 complexed to the antiviral OBR-5-340 reveals unexpected binding site.
Wald J; Pasin M; Richter M; Walther C; Mathai N; Kirchmair J; Makarov VA; Goessweiner-Mohr N; Marlovits TC; Zanella I; Real-Hohn A; Verdaguer N; Blaas D; Schmidtke M
Proc Natl Acad Sci U S A; 2019 Sep; 116(38):19109-19115. PubMed ID: 31462495
[TBL] [Abstract][Full Text] [Related]
13. Effect of lipophilicity modulation on inhibition of human rhinovirus capsid binders.
Morley A; Tomkinson N; Cook A; MacDonald C; Weaver R; King S; Jenkinson L; Unitt J; McCrae C; Phillips T
Bioorg Med Chem Lett; 2011 Oct; 21(20):6031-5. PubMed ID: 21907579
[TBL] [Abstract][Full Text] [Related]
14. SDZ 35-682, a new picornavirus capsid-binding agent with potent antiviral activity.
Rosenwirth B; Oren DA; Arnold E; Kis ZL; Eggers HJ
Antiviral Res; 1995 Jan; 26(1):65-82. PubMed ID: 7741522
[TBL] [Abstract][Full Text] [Related]
15. Heterocyclic pharmacochemistry of new rhinovirus antiviral agents: A combined computational and experimental study.
Da Costa L; Scheers E; Coluccia A; Rosetti A; Roche M; Neyts J; Terme T; Cirilli R; Mirabelli C; Silvestri R; Vanelle P
Eur J Med Chem; 2017 Nov; 140():528-541. PubMed ID: 28987610
[TBL] [Abstract][Full Text] [Related]
16. Antiviral activity of the zinc ionophores pyrithione and hinokitiol against picornavirus infections.
Krenn BM; Gaudernak E; Holzer B; Lanke K; Van Kuppeveld FJ; Seipelt J
J Virol; 2009 Jan; 83(1):58-64. PubMed ID: 18922875
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and in vitro evaluation of novel chroman-4-one, chroman, and 2H-chromene derivatives as human rhinovirus capsid-binding inhibitors.
Conti C; Proietti Monaco L; Desideri N
Bioorg Med Chem; 2011 Dec; 19(24):7357-64. PubMed ID: 22088306
[TBL] [Abstract][Full Text] [Related]
18. Anti-rhinovirus activity of 3-methylthio-5-aryl-4-isothiazolecarbonitrile derivatives.
Garozzo A; Cutrì CC; Castro A; Tempera G; Guerrera F; Sarvà MC; Geremia E
Antiviral Res; 2000 Mar; 45(3):199-210. PubMed ID: 10771083
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antirhinovirus activity of new 3-benzyl chromene and chroman derivatives.
Conti C; Desideri N
Bioorg Med Chem; 2009 May; 17(10):3720-7. PubMed ID: 19398344
[TBL] [Abstract][Full Text] [Related]
20. VP1 crystal structure-guided exploration and optimization of 4,5-dimethoxybenzene-based inhibitors of rhinovirus 14 infection.
Da Costa L; Roche M; Scheers E; Coluccia A; Neyts J; Terme T; Leyssen P; Silvestri R; Vanelle P
Eur J Med Chem; 2016 Jun; 115():453-62. PubMed ID: 27049678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
